aspirin has been researched along with ethyl cellulose in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Noro, S; Uesugi, T; Yoshida, H | 1 |
Hashida, M; Wu, X; Yamashita, F | 1 |
Brohede, U; Frenning, G; Strømme, M | 1 |
Gou, J; He, H; Li, R; Tang, X; Yin, T; Zhang, Y | 1 |
Kamalasanan, K; Moidu, A; Nair, LJ; P, V; Shyamsundar, P; Thrivikraman Nair, S | 1 |
5 other study(ies) available for aspirin and ethyl cellulose
Article | Year |
---|---|
[The effect of physical condition in second emulsification for yield of microcapsules (author's transl)].
Topics: Animals; Aspirin; Capsules; Cellulose; Chemistry, Pharmaceutical; Emulsions; Male; Rabbits | 1980 |
Deconvolution analysis for absorption and metabolism of aspirin in microcapsules.
Topics: Absorption; Acrylic Resins; Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Capsules; Cellulose; Chromatography, High Pressure Liquid; Excipients; Gels; Male; Models, Biological; Polymethacrylic Acids; Rats; Rats, Wistar; Solubility | 1999 |
Finite element analysis of the release of slowly dissolving drugs from cylindrical matrix systems.
Topics: Algorithms; Anisotropy; Aspirin; Cellulose; Chemistry, Pharmaceutical; Diffusion; Drug Carriers; Finite Element Analysis; Models, Statistical; Solubility; Tablets | 2005 |
Preparing of aspirin sustained-release granules by hot-melt granulation and micro-crystal coating.
Topics: Aspirin; Cellulose; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Drug Stability; Excipients; Platelet Aggregation Inhibitors; Solubility; Stroke | 2019 |
Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations.
Topics: Aspirin; Cellulose; COVID-19 Drug Treatment; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Humans; SARS-CoV-2 | 2021 |